Skip to main content
Fig. 6 | Microbial Cell Factories

Fig. 6

From: Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection

Fig. 6

Gastric histology and protective effects were investigated. (a) Experimental protocol for preventing the efficacy of recombinant L. lactis vaccination in the treatment H. pylori infection in BALB/c mice. (b) qPCR analysis of H. pylori. (c) CFU counting of bacterial colonies per mouse stomach. (d) Detection of urease activity at OD550 nm. (e-f) Gastric histological characterization (HE staining 100× and inflammation score). (g) Immunohistochemistry of the gastric tissue (100×). Tissue sections were counted for positive spots, which indicate the number of H. pylori- positive cells

Back to article page